CRMD

Cormedix Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 9/10
  • Value↑ 5/10
Cormedix sales and earnings growth
CRMD Growth
Great
  • Revenue Y/Y↑ 617.03%
  • EPS Y/Y↑ 850.00%
  • FCF Y/Y↑ 440.59%
Cormedix gross and profit margin trends
CRMD Profitability
Great
  • Gross margin ↑ 88.50%
  • EPS margin↑ 52.30%
  • ROIC 5Y↑ -83.52%
Cormedix net debt vs free cash flow
CRMD Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 54.9

Cormedix stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks